Le Lézard
Classified in: Health
Subject: OBI

i360medical Confirms Untimely Passing Of CEO Derek Young


DUBLIN, Dec. 3, 2021 /PRNewswire/ -- i360medical, a leading Irish healthcare innovation and medical device company, confirms the untimely passing of Founder and CEO Derek Young.

Mr. Young, 51, had battled with an underlying illness for many years and passed away at the Hermitage Clinic in Dublin earlier this week.

Mr. Young established i360medical in 2009. Over the last decade the company established itself as a preferred 'one stop' supplier of outsourced R & D for a number of global and national healthcare systems and medical technology companies.

Describing Mr. Young as a visionary and one of Ireland's leading healthcare entrepreneurs and innovators, the Chair of the company and interim CEO Bob Mitchell extended his sympathies on behalf of everyone at i360 to Mr. Young's family and friends.

"Derek was the proud founder and driving force behind i360medical. He was a deeply connected, accomplished innovator and leader in the medical device industry but the true legacy he leaves behind is that of a husband, father, and friend."

"Our thoughts first of all are with Derek's wife Suzanne, children India, Xavier and Pixie, his family and his wide circle of friends in Wexford, Dublin, New Zealand, the United States, Europe and beyond, on their terrible loss."

"Derek's vision for i360medical was to improve patient care and outcomes by firstly identifying and then providing innovative solutions. i360medical is now recognised as a global leader in the medical device innovation sector. As a Board and Management Team we are committed to delivering on the sustainable vision Derek and his colleagues have created and ensuring it continues into the future."

A named inventor of over 32 patents with commercial success globally, Derek Young was involved in a number of successful European medical device start-up companies including Medtech, Advanced Surgical Concepts and Haptica before spinning into the Royal College of Surgeons (RCSI) in Dublin.

He spearheaded and completed at least a dozen medical device exits with key multinational healthcare corporations over the last 12 years.

Mr. Young's funeral will take place at St Brigid's church, Blackwater, Co. Wexford at 11am on Saturday, 4th of December. Death Notice of Derek William Young (rip.ie)

iThree Sixty Medical Limited t/a i360medical
The Masonry, 151-156 Thomas Street, Usher's Island, Dublin, D08 PY5E. 
Tel:  +353 1 620 3684 E-mail:  [email protected]

CONTACT:
Rachel Knutton 
+1-931-252-8000
[email protected]

SOURCE i360medical


These press releases may also interest you

at 22:00
Frost & Sullivan recently analyzed the hospital industry and noted that operational inefficiencies, workflow interruptions and shortage of skilled healthcare professionals are some key challenges faced by the healthcare industry. Based on its...

at 20:14
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...

at 19:30
The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against agilon health, inc. ("agilon" or the "Company").  This action, captioned Hope v. agilon health, inc., et...

at 18:00
bioLytical Laboratories Inc. announced today the immediate availability of its INSTI® HCV Antibody Test in the Australian market.  The INSTI Hepatitis C (HCV) Antibody Test is now included in the Australian Register of Therapeutic Goods (ARTG...

at 17:20
The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of blood eosinophil counts (BEC) and irrespective of emphysema, chronic bronchitis or...

at 14:15
Endeavor BioMedicines, a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients with life-threatening diseases, announced results from a completed Phase 2a clinical trial...



News published on and distributed by: